echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > HPV vaccine! Merck's Gardasil 9 (Gawei vaccine, 9 price) has been approved by the US FDA to prevent oropharyngeal cancer and other head and neck cancers!

    HPV vaccine! Merck's Gardasil 9 (Gawei vaccine, 9 price) has been approved by the US FDA to prevent oropharyngeal cancer and other head and neck cancers!

    • Last Update: 2020-06-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guidance: According to a recently released model by the Centers for Disease Control and Prevention (CDC), HPV has overtaken cervical cancer to become the most common HPV-related cancer in the United States
    Merck andCoThis oral and head and neck cancer indicationisis is accelerated based on the effectiveness of Gardasil9 in the prevention of HPV-related genital diseasesThe ongoing approval of the indications may depend on the validation and description of clinical benefits in validation trials, which are currently under wayDr Alain Luxembourg, director of clinical research at the's Mercado Research Laboratory, said: "At Mercadon, for more than 20 years, efforts to help prevent certain HPV-related cancers have been a priorityToday's approval to prevent HPV-related pharynx and other head and neck cancers represents a major step forward in Mershadon's mission to help reduce the number of men and women affected by certain HPV-related cancers"
    Gardasil9 is a human papillomavirus (HPV) vaccine for women aged 9-45 years:(1) for the prevention of cervical, vulva, vagina, anus, pharynx and other cervical and other cervical cancers caused by seven high-risk types of HPV (16, 18, 31, 33, 45, 52, 58);(2) is used to prevent 9 types of HPV (6, 11, 16, 18, 31, 33, 45, 52, 58) caused by cervical, vulva, anal cancer precancerous lesions or abnormal increase diswelling;Gardasil9 is suitable for men aged 9-45 years:(1) for the prevention of, pharynx and other head and neck cancers caused by 7 types of high-risk HPV (16, 18, 31, 33, 45, 52, 58);(2) is used to prevent pre-anal cancer lesions or abnormal increases caused by 9 types of HPV (6, 11, 16, 18, 31, 33, 45, 52, 58), and(3) for the prevention of genital warts caused by 2 types of low-risk HPV (6, 11) In 2019, Gardasil/Gardasil9's global sales reached $3.737 billion, up 19 percent from the previous year both men and women are likely to develop HPV-induced pharynx cancer; For most people, HPV will clean itself up However, for those who fail to remove the virus, it can cause certain cancers Oral pharynx cancer can be caused by HPV infection in the mouth and throat, which includes the soft palate, the side wall of the throat and the back wall, the tonsils and the back third of the tongue according to a recently released model by the Centers for Disease Control and Prevention (CDC), HPV causes more oral cancer than cervical cancer, making it the most common HPV-related cancer in the United States original source: FDA approves Merck's GARDASIL 9 for the Prevention of HPV-About Head and Cancer
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.